|
Name |
paecilin P
|
Molecular Formula | C34H38O16 | |
IUPAC Name* |
methyl5-hydroxy-6-[5-hydroxy-2-(1-hydroxy-4-methoxy-2-methyl-4-oxobutyl)-2-methoxycarbonyl-4-oxo-3H-chromen-6-yl]-2-(1-hydroxy-4-methoxy-2-methyl-4-oxobutyl)-4-oxo-3H-chromene-2-carboxylate
|
|
SMILES |
COC(=O)CC(C)C(O)C1(C(=O)OC)CC(=O)c2c(ccc(-c3ccc4c(c3O)C(=O)CC(C(=O)OC)(C(O)C(C)CC(=O)OC)O4)c2O)O1
|
|
InChI |
InChI=1S/C34H38O16/c1-15(11-23(37)45-3)29(41)33(31(43)47-5)13-19(35)25-21(49-33)9-7-17(27(25)39)18-8-10-22-26(28(18)40)20(36)14-34(50-22,32(44)48-6)30(42)16(2)12-24(38)46-4/h7-10,15-16,29-30,39-42H,11-14H2,1-6H3/t15-,16-,29+,30+,33-,34-/m0/s1
|
|
InChIKey |
ZBMSEZQDWPRKQA-NHHXLWFISA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 702.66 | ALogp: | 1.6 |
HBD: | 4 | HBA: | 16 |
Rotatable Bonds: | 11 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 238.7 | Aromatic Rings: | 4 |
Heavy Atoms: | 50 | QED Weighted: | 0.194 |
Caco-2 Permeability: | -5.495 | MDCK Permeability: | 0.00001520 |
Pgp-inhibitor: | 0.376 | Pgp-substrate: | 0.323 |
Human Intestinal Absorption (HIA): | 0.928 | 20% Bioavailability (F20%): | 0.012 |
30% Bioavailability (F30%): | 0.981 |
Blood-Brain-Barrier Penetration (BBB): | 0.052 | Plasma Protein Binding (PPB): | 76.22% |
Volume Distribution (VD): | 0.502 | Fu: | 15.90% |
CYP1A2-inhibitor: | 0.011 | CYP1A2-substrate: | 0.533 |
CYP2C19-inhibitor: | 0.031 | CYP2C19-substrate: | 0.338 |
CYP2C9-inhibitor: | 0.118 | CYP2C9-substrate: | 0.391 |
CYP2D6-inhibitor: | 0.007 | CYP2D6-substrate: | 0.179 |
CYP3A4-inhibitor: | 0.852 | CYP3A4-substrate: | 0.666 |
Clearance (CL): | 10.817 | Half-life (T1/2): | 0.271 |
hERG Blockers: | 0.011 | Human Hepatotoxicity (H-HT): | 0.863 |
Drug-inuced Liver Injury (DILI): | 0.97 | AMES Toxicity: | 0.029 |
Rat Oral Acute Toxicity: | 0.802 | Maximum Recommended Daily Dose: | 0.018 |
Skin Sensitization: | 0.005 | Carcinogencity: | 0.034 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.007 |
Respiratory Toxicity: | 0.006 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005728 | 0.887 | D0T5XN | 0.261 | ||||
ENC005735 | 0.692 | D07IPB | 0.248 | ||||
ENC003347 | 0.665 | D0Q0PR | 0.228 | ||||
ENC005736 | 0.648 | D01XWG | 0.228 | ||||
ENC005734 | 0.631 | D01XDL | 0.228 | ||||
ENC005727 | 0.620 | D07VLY | 0.224 | ||||
ENC003346 | 0.604 | D0C9XJ | 0.224 | ||||
ENC005729 | 0.571 | D01UBX | 0.221 | ||||
ENC005732 | 0.544 | D03KIA | 0.219 | ||||
ENC005730 | 0.538 | D0N1FS | 0.218 |